Polyphor is a privately owned Swiss biotech company founded in 1996.

 

The Small Molecules Business Unit (SMBU) provides the pharmaceutical industry with innovative, high quality products and services in the area of drug discovery.

 

The Protein Epitope Mimetics Business Unit (PEMBU) conducts its own drug discovery and clinical development programs based on the proprietary PEM Technology.
Polyphor also offers PEM Technology for collaborations on customer's targets.

 

 

Polyphor Ltd.
Hegenheimermattweg 125
CH-4123 Allschwil
Switzerland
Tel. +41 61 567 16 00
Fax +41 61 567 16 01
info@polyphor.com